The latest news from our lab, featuring our groundbreaking discovery of new therapeutics, is showcased here.
We are delighted to share that our latest research has been published in Chemistry – A European Journal. The study highlights a promising new route to develop pyrrolo[2,1-c][1,4]benzodiazepine (PBD)-based DNA…
We are delighted to share that our Principal Investigator, Dr. M. M. Hasan, has been promoted to Associate Professor in the recent Syndicate meeting of the University of Chittagong held…
We are proud to announce that our recent work has been published in the Journal of Medicinal Chemistry, the flagship journal in drug discovery. This study addresses one of today’s…
We are pleased to announce that our team has published a landmark study describing the first pyrrolobenzodiazepine (PBD)-based proteolysis-targeting chimera (PROTAC), opening a new therapeutic avenue for cancers driven by…
আমাদের লাইফ সাইন্স এন্ড মেডিসিন ফ্যাকাল্টি এর উদ্যোগে প্রায়ই “ইন্সপাইরেশনাল টকস” আয়োজন হয়। এটার আরেকটা নাম হলো “Inaugural Lectures”! মানে হলো, এই ফ্যাকাল্টিতে যারা প্রফেসর পদে প্রমোশন পায় তাদের থেকে…
If you are interested about who we are please go through the individual section below.
We are working with different research groups having expertise in diverse scientific areas including drug discovery, medicinal chemistry, microbiology, genetic engineering and public health.
Our prime focus is to utilize medicinal chemistry tools to design and synthesis novel drug scaffolds targeting Cancer and Antimicrobial resistance.
We are trying to understand the genetic basis of diseases especially diabetes and thalassemia using molecular biology techniques like sequencing.
We are addressing emerging problems most of them are neglected in Bangladesh. The major area of research includes Thalassemia, Chikungunya and Dengue.
To date 8 research students are worked with Hasan lab at University of Chittagong. To know about their experience with us please read the testimony below.
